Master10
Public Health, Nutrition & Epidemics20 Concepts & Facts

7th National Formulary of India 2026 GK Facts, Overview & Study Guide

Reviewed by the Master10 Editorial Board for accuracy, clarity and competitive-exam relevance.Editorial Policy
The National Formulary of India is an official reference compendium published by the Indian Pharmacopoeia Commission, an autonomous institution operating under the Ministry of Health and Family Welfare with headquarters in Ghaziabad, Uttar Pradesh. Conceived as an authoritative clinical guide for physicians, pharmacists, nurses, and medical educators, the 7th National Formulary of India 2026 provides evidence-based guidance on the rational, safe, and cost-effective prescription of therapeutic drugs. By compiling standardized monographs on essential pharmaceuticals, the publication curtails irrational prescribing habits, minimises medication errors, and encourages scientific prescription writing across primary, secondary, and tertiary healthcare tiers.

Historically, the first edition of the National Formulary of India was published in 1960 to establish domestic therapeutic standards in independent India. Subsequent revisions, culminating in the modern editions, have adapted to shifting disease burdens, newly discovered therapeutic molecules, and changing epidemiological profiles. The formulary incorporates medicines recognized within the National List of Essential Medicines and aligns with World Health Organization Model Formulary principles. Each drug monograph provides verified details regarding therapeutic indications, approved dosages, adverse drug reaction profiles, clinical contraindications, dangerous drug-drug interactions, and cautionary guidelines for pregnant women, pediatric patients, and elderly populations.

Beyond therapeutic dosages, the 7th edition addresses urgent national health challenges, including antimicrobial resistance, biosimilar pharmacovigilance, and generic substitution. In coordination with the Pharmacovigilance Programme of India, the compendium trains healthcare personnel to identify and document adverse drug reactions through official reporting channels. Detailed guidance covers dose adjustments for renal and hepatic impairment, calculation of pediatric doses by body surface area, and safe handling of look-alike sound-alike medications. Specialized prescribing sections address therapeutic drug monitoring for compounds with narrow safety margins, safe disposal of expired pharmaceuticals, and emergency interventions for acute anaphylactic shock. By promoting the prescription of quality-assured generic formulations, the formulary reinforces affordable healthcare initiatives like the Pradhan Mantri Bhartiya Janaushadhi Pariyojana, protecting citizens from catastrophic out-of-pocket medical expenditures while upholding rigorous clinical safety standards.

Key Concepts & Self-Assessment20 Key Facts

Review key 7th National Formulary of India 2026: Rational Medicine Use and Drug Safety exam facts and rate your mastery to track revision.

Progress: 0/20 Rated 0 Mastered 0 Review Later
#1
The National Formulary of India (NFI) is compiled and released by the Indian Pharmacopoeia Commission (IPC), Ghaziabad.
#2
The Indian Pharmacopoeia Commission functions as an autonomous institution under the Ministry of Health and Family Welfare.
#3
The inaugural 1st edition of the National Formulary of India was officially published by the Government of India in 1960.
#4
The publication establishes evidence-based clinical standards to promote the rational and cost-effective use of medicines.
#5
Drug monographs detail approved clinical indications, dosage regimens, adverse drug reactions, and specific contraindications.
#6
The formulary aligns closely with the National List of Essential Medicines (NLEM) formulated by the Union Health Ministry.
#7
International standards established in the World Health Organization (WHO) Model Formulary guide the editorial curation.
#8
The compendium functions as an authoritative prescribing reference for medical practitioners, pharmacists, and nursing staff.
#9
Specialized chapters provide safety precautions for administering medicines to pediatric, pregnant, and geriatric patients.
#10
The document integrates guidelines from the Pharmacovigilance Programme of India (PvPI) to monitor Adverse Drug Reactions (ADRs).
#11
Healthcare professionals use NFI protocols to distinguish between minor drug side-effects and life-threatening toxic reactions.
#12
A dedicated focus on Antimicrobial Stewardship provides guidance to combat the emergence of antimicrobial resistance (AMR).
#13
Emergency management protocols for poisoning, acute drug toxicity, and anaphylactic shock are detailed within the manual.
#14
The formulary advocates the prescription of generic drug formulations over expensive branded pharmaceutical alternatives.
#15
NFI guidelines support the Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) by verifying therapeutic equivalence of generics.
#16
Rules governing drug manufacture, testing, and distribution derive legal authority from the Drugs and Cosmetics Act, 1940.
#17
Storage instructions and cold-chain stability requirements for temperature-sensitive biologics and vaccines are highlighted.
#18
Monographs outline known drug interactions when multiple therapeutic agents are prescribed concurrently to manage comorbidities.
#19
Regular revisions ensure that obsolete drugs with unfavorable benefit-to-risk ratios are removed from active guidance.
#20
Digital versions and mobile applications of the NFI facilitate rapid clinical lookups in hospital wards and primary health centres.

Subject Specialist Commentary

Analytical perspective & practical exam advice from the Master10 academic board

Educator's Insight
The National Formulary of India is an authoritative clinical guide published by the Indian Pharmacopoeia Commission to promote the rational, safe, and cost-effective use of medicines. First issued in 1960, the updated seventh edition provides doctors, pharmacists, and healthcare professionals with unbiased prescribing guidance. It details approved drug dosages, adverse reactions, and dangerous contraindications, ensuring patients receive scientifically validated treatments while curbing the dangerous overprescription of antibiotics and expensive brand-name medications.
For UPSC and State PSC health policy questions, candidates should note the institutional distinction between the Indian Pharmacopoeia Commission in Ghaziabad and the Central Drugs Standard Control Organisation in New Delhi. While CDSCO is the regulatory drug-licensing authority under the Drugs and Cosmetics Act, IPC curates therapeutic drug standards and the formulary under the Ministry of Health. A recurring prelims trap confuses the National Formulary with the National List of Essential Medicines; the formulary provides prescribing guidelines aligned with the NLEM.

Related Knowledge Topics to Discover

Public Health, Nutrition & Epidemics
What Is the Global Mpox Vaccine Stockpile and How Will It Improve Outbreak Response?

Understand the Global Mpox Vaccine Stockpile, the Access and Allocation Mechanism, MVA-BN and LC16m8 vaccines, Clade I and II biology, and outbreak containment.

Explore Topic
Public Health, Nutrition & Epidemics
What Is SPECS 2030 and Why Is Global Access to Vision Care a Challenge?

Explore WHO SPECS 2030 initiative, refractive errors, effective coverage targets (eCRE), public health challenges, and socioeconomic impacts of vision care.

Explore Topic
Public Health, Nutrition & Epidemics
What Is World Patient Safety Day 2026 and Why Is Safe Care for Noncommunicable Diseases Important?

Learn about World Patient Safety Day, safe care for noncommunicable diseases, polypharmacy risks, WHO Global Patient Safety Action Plan, and clinical safety.

Explore Topic

Looking for more GK practice?

Explore 52,789+ questions across 65 General Knowledge categories.

Open Interactive Search